Based on the certificate received from R&T agents, TSR Darashaw, Bal Pharma has confirmed that the details of securities dematerialized/ rematerialized during the quarter ended on 30.06.2021 have been furnished to all the stock exchanges where the equity shares of the Company are listed, within the prescribed time limit. The Share certificates received for dematerialization, if any has been mutilated and cancelled after due verification and the name of the depository has been substituted in the records as registered owner, within 15 days of the receipt of the certificate of security.
The above information is a part of company’s filings submitted to BSE.
